by Proxiva Peptides | Mar 29, 2026 | Nootropics, Peptide Research
PE-22-28 (Spadin Analog PE-22-28) has emerged as one of the most studied peptides in modern biomedical research. With its 7 amino acids structure, this compound has attracted attention from researchers worldwide for its potential roles in TREK-1 inhibitor and...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Research Guides
In the ever-expanding landscape of peptide research, Dihexa occupies a notable position. This modified hexapeptide compound has been the subject of numerous studies investigating its role in memory enhancement and synaptogenesis. This article provides a detailed...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Peptide Research
Semax, also known as Semax Heptapeptide, is a 7 amino acids peptide that has garnered significant attention in the research community. Studies have explored its potential in ACTH analog, BDNF increase, and related fields, yielding a growing body of evidence that...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Research Guides
Research into Selank represents a fascinating intersection of molecular biology, pharmacology, and translational science. This 7 amino acids compound has shown promise in areas ranging from BDNF modulation to cognitive enhancement, making it a subject of considerable...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Research Guides
Among the many peptides under active investigation, PE-22-28 stands out for its unique properties and versatile research applications. Originally studied for its effects on TREK-1 inhibitor, researchers have since discovered connections to cognitive function,...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Peptide Research
Dihexa (Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide)) has emerged as one of the most studied peptides in modern biomedical research. With its modified hexapeptide structure, this compound has attracted attention from researchers worldwide for its potential...
